ToGA trial and how it changed the management of HER2+ gastric carcinoma Annual Meeting GI 2016

ToGA trial and how it changed the management of HER2+ gastric carcinoma Annual Meeting GI 2016

915 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Daniel Catenacci, MD of The University of Chicago Medicine discusses the ToGA trial and how it changed the management of HER2+ gastric carcinoma at ASCO GI 2016
Up Next Autoplay